News
Reported first quarter 2025 revenues of $87.1 million with 62% year-over-year growth of exome and genome test revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback